To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M
Study sponsor: Bioxytran Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12Estimated
Enrollment · participants40Estimated
Source updated2023-09-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.